Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 10, Octobre 2013
Page(s) 861 - 867
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20132910013
Publié en ligne 18 octobre 2013
  1. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002 ; 297 : 2056–2060. [CrossRef] [PubMed]
  2. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005 ; 435 : 834–838. [CrossRef] [PubMed]
  3. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006 ; 103 : 2257–2261. [CrossRef]
  4. Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008 ; 47 : 1955–1963. [CrossRef] [PubMed]
  5. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006 ; 25 : 2537–2545. [CrossRef] [PubMed]
  6. Boyault S, Rickman DS, de Reynies A, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007 ; 45 : 42–52. [CrossRef] [PubMed]
  7. Sekine S, Ogawa R, Ito R, et al. Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. Gastroenterology 2009 ; 136 : 2304–2315.e1–4. [CrossRef] [PubMed]
  8. Sekine S, Ogawa R, McManus MT, et al. Dicer is required for proper liver zonation. J Pathol 2009 ; 219 : 365–372. [CrossRef] [PubMed]
  9. Wang XW, Heegaard NH, Orum H. MicroRNAs in liver disease. Gastroenterology 2012 ; 142 : 1431–1443. [CrossRef] [PubMed]
  10. Wen J, Friedman JR. miR-122 regulates hepatic lipid metabolism and tumor suppression. J Clin Investig 2012 ; 122 : 2773–2776. [CrossRef]
  11. Vaulont S. miR-122, un microARN « à tout fer ». Med Sci (Paris) 2011 ; 27 : 704–706. [CrossRef] [EDP Sciences] [PubMed]
  12. Law PT, Wong N. Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol 2011 ; 26 : 437–449. [CrossRef] [PubMed]
  13. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010 ; 327 : 198–201. [CrossRef] [PubMed]
  14. Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013 ; 368 : 1685–1694. [CrossRef] [PubMed]
  15. Bala S, Marcos M, Kodys K, et al. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem 2011 ; 286 : 1436–1444. [CrossRef] [PubMed]
  16. Bala S, Petrasek J, Mundkur S, et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012 ; 56 : 1946–1957. [CrossRef] [PubMed]
  17. Yan XL, Jia YL, Chen L, et al. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: Role of the S100A4-miR155-SOCS1-MMP9 axis. Hepatology 2013 ; doi : 10.1002/hep.26257.
  18. Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011 ; 19 : 232–243. [CrossRef] [PubMed]
  19. Xiong Y, Fang JH, Yun JP, et al. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 2010 ; 51 : 836–845. [PubMed]
  20. Pineau P, Volinia S, McJunkin K, et al. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 2010 ; 107 : 264–269. [CrossRef]
  21. Cairo S, Wang Y, de Reynies A, et al. Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci USA 2010 ; 107 : 20471–20476. [CrossRef]
  22. Giordano S, Columbano A. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 2013 ; 57 : 840–847. [CrossRef] [PubMed]
  23. Zucman-Rossi J. Molecular classification of hepatocellular carcinoma. Dig Liver Dis 2010 ; 42 Suppl 3 : S235–S241. [CrossRef] [PubMed]
  24. Liu WH, Yeh SH, Lu CC, et al. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009 ; 136 : 683–693. [CrossRef] [PubMed]
  25. Ladeiro Y, Zucman-Rossi J. Micro-ARN (miARN) et cancer : le cas des tumeurs hépatocellulaires. Med Sci (Paris) 2009 ; 25 : 467–472. [CrossRef] [EDP Sciences] [PubMed]
  26. Wong CM, Wong CC, Lee JM, et al. Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis. Hepatology 2012 ; 55 : 1453–1461. [CrossRef] [PubMed]
  27. Budhu A, Jia HL, Forgues M, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008 ; 47 : 897–907. [CrossRef] [PubMed]
  28. Li LM, Hu ZB, Zhou ZX, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 2010 ; 70 : 9798–9807. [CrossRef] [PubMed]
  29. Zhou J, Yu L, Gao X, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011 ; 29 : 4781–4788. [CrossRef] [PubMed]
  30. Park JK, Kogure T, Nuovo GJ, et al. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res 2011 ; 71 : 7608–7616. [CrossRef] [PubMed]
  31. Obad S, dos Santos CO, Petri A, et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 2011 ; 43 : 371–378. [CrossRef] [PubMed]
  32. Kota J, Chivukula RR, O’Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009 ; 137 : 1005–1017. [CrossRef] [PubMed]
  33. Hatziapostolou M, Polytarchou C, Aggelidou E, et al. An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 2011 ; 147 : 1233–1247. [CrossRef] [PubMed]
  34. Muller S, Raman Pandey R, Pillai RS. Les piARN forgent un système immunitaire pour le génome. Med Sci (Paris) 2013 ; 29 : 487–494. [CrossRef] [EDP Sciences] [PubMed]
  35. Lemaigre F. Le développement des lignages hépatiques dans le foie normal et durant la régénération. Med Sci (Paris) 2012 ; 28 : 958–962. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.